Results 141 to 150 of about 23,408 (219)

Lithium Dispensing Patterns in Dutch Youth: Prevalence, Incidence Dosages, and Duration of Use From 2011 to 2022

Bipolar Disorders, Volume 28, Issue 5, August 2026.
ABSTRACT Objective Bipolar disorder (BD) often emerges during mid‐adolescence and young adulthood, and leads to functional and social impairment, with a prevalence of 0.87% among Dutch youth. Lithium, the first‐line BD maintenance treatment, stabilizes mood, prevents suicide, and is well tolerated, yet its use has declined as long‐term second ...
Ravish N. Gangapersad, Lisa T. Ringeling, Jens H. J. Bos, Birgit C. P. Koch, Manon H. J. Hillegers, Pilar Garcia‐Gomez, Catharina C. M. Schuiling‐Veninga, Eelko Hak, Bram Dierckx   +8 more
wiley   +1 more source

Comparison of effectiveness and side effects of selegiline transdermal system versus oral monoamine oxidase inhibitors and tricyclic antidepressants for treatment-resistant depression. [PDF]

J Affect Disord
Kim TT, Xu C, Amsterdam JD.
europepmc   +1 more source

Endothelium‐ and epithelium‐derived novel endogenous catecholamines as modulators of the autonomic nervous system

British Journal of Pharmacology, Volume 183, Issue 15, Page 4091-4110, August 2026.
Abstract Catecholamines are classically viewed as neuronal transmitters and adrenal hormones; however, accumulating evidence demonstrates that sources other than nerve fibres and adrenal medulla play a fundamental role in local organ regulation. Physiological paradoxes, such as preserved organ function after denervation or transplantation, challenge a ...
Mariana G. de Oliveira, Edson Antunes, Fabiola Zakia Monica, Gilberto De Nucci   +3 more
wiley   +1 more source

Design, Synthesis, and Biological Effect Studies of Novel Benzofuran-Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors. [PDF]

ACS Omega
Osmani Ye D, Sağlik BN, Levent S, Çevi K UA, Ilgin S, Yurttaş L, Özkay Y, Karaburun AC, Kaplancikli ZA, Gundogdu-Karaburun N.   +9 more
europepmc   +1 more source

Towards the Prevention of Freezing of Gait in Parkinson's Disease

European Journal of Neuroscience, Volume 64, Issue 4, August 2026.
Freezing of gait (FOG) is a disabling complication of Parkinson's disease (PD) that remains difficult to treat. Targeting modifiable risk factors and implementing pleiotropic (lifestyle) interventions before FOG onset may potentially delay or prevent its development.
Anouk Tosserams, Jorik Nonnekes, Bastiaan R. Bloem, Elbrich M. Postma   +3 more
wiley   +1 more source

Improvement in Quality of Life and Non‐Motor Symptoms Associated With OFF Episodes in People With Parkinson's Disease Treated With Inhaled Levodopa

European Journal of Neurology, Volume 33, Issue 8, August 2026.
The open prospective multicenter INLEVO‐LIFE PD study showed in 40 patients with Parkinson's disease after 3 months of use of inhaled levodopa for OFF episodes an improvement in health‐related quality of life (primary endpoint) and also, as highlighted data, an effect of at least 90 min after its administration not only on motor status (UPDRS‐III) but ...
Diego Santos García, María Cerdán Sánchez, Rosa Yáñez Baña, Iria Cabo, Maria Icíar Cimas Hernando   +4 more
wiley   +1 more source

<i>In Vitro</i> and <i>In Silico</i> ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases. [PDF]

ACS Chem Neurosci, 2020
Więckowska A, Szałaj N, Góral I, Bucki A, Latacz G, Kiec-Kononowicz K, Bautista-Aguilera ÒM, Romero A, Ramos E, Egea J, Farré Alíns V, González-Rodríguez Á, López-Muñoz F, Chioua M, Marco-Contelles J.   +14 more
europepmc   +1 more source

Catecholamines Activate a Tumour Progression Program in Differentiated Tumour Hepatocytes

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background and Aims The sympathetic nervous system is involved in the progression and aggressiveness of several cancers, including hepatocellular carcinoma (HCC). However, the specific effects of sympathetic innervation and catecholamines on tumour hepatocyte behaviour remain poorly understood.
Elise Lelou, Claudine Rauch, Hélène Dubois‐Pot‐Schneider, Marjorie Dufresne, Abolfazl Zekri Yazdi, Maelle Guillout, Luis Cano, Lise Desquilles, Nicolas Nesseler, Marc Bourgeois, Claude Bendavid, Julie Massart, Orlando Musso, Anne Corlu, Caroline Aninat   +14 more
wiley   +1 more source

Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings. [PDF]

Neural Regen Res
Alborghetti M, Bianchini E, De Carolis L, Galli S, Pontieri FE, Rinaldi D.   +5 more
europepmc   +1 more source

Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease. [PDF]

RSC Med Chem, 2020
Wang XB, Yin FC, Huang M, Jiang N, Lan JS, Kong LY.   +5 more
europepmc   +1 more source